Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CORAL LABORATORIES LTD.

NSE : NABSE : 524506ISIN CODE : INE683E01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE520.9039.9 (+8.3 %)

PREV CLOSE ( ) 481.00

OPEN PRICE ( ) 478.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2673

TODAY'S LOW / HIGH ( )470.00 544.90

52 WK LOW / HIGH ( ) 442.55999

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1997

Management Info

- Chairman - Managing Director

Registered Office

Address 3 B Patanwala Industrial Estate,Opp. Shreyas Cinema,L B S Marg, Ghatkopar (West),
Mumbai,
Maharashtra-400086

Phone 022-25008208 / 25005245/46

Email accounts@corallab.com

Website www.corallab.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

27Jun Coral Laboratories informs about closu
Coral Laboratories has informed that pursuant to SEBI (Prohibition of In..

31Dec Coral Laboratories informs about issua
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

04Sep Coral Laboratories informs about newsp
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

13Jul Coral Laboratories informs about appoi
Coral Laboratories has informed about appointment of Ms. Dhwani Desai as..

04Jul Coral Laboratories informs about resig
Coral Laboratories has informed that, Ruchi Pipara has resigned from the..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	25.65	241.54
Gross Profit	37.2	324.69
Operating Profit	42.31	353.48
Net Sales	188.21	1150.05

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Glenmark Pharma (BSE) 2053.50 (3.16%)	M.Cap ( in Cr)57949.94
Acutaas Chemicals (BSE) 1475.10 (3.49%)	M.Cap ( in Cr)12076.48
Amrutanjan Healthcar (BSE) 769.30 (5.17%)	M.Cap ( in Cr)2224.09
Blue Jet Healthcare (BSE) 744.20 (4.99%)	M.Cap ( in Cr)12909.30
Alkem Laboratories (BSE) 5336.45 (0.61%)	M.Cap ( in Cr)63805.26

Shareholding Pattern

	PROMOTERS	71.51%
	NON-INSTITUTION	28.5%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

CORAL LABORATORIES LTD.